Hepatitis B antigen: advancement in knowledge quickens. (A review).
For many years viral hepatitis and its causative agent have been an enigma to investigators. In the last decade there has been such an increase of information on the subject that it challenges one's ability to keep abreast of the advancement in knowledge. The purpose of this paper is to bring into focus some of the latest developments with regard to viral hepatitis B and its causative agent.
D000208:Acute Disease; D000914:Antibodies, Viral / Q000032:analysis; D002353:Carrier State / Q000276:immunology; D002908:Chronic Disease; D000939:Epitopes; D006509:Hepatitis B / Q000276:immunology / Q000517:prevention & control; D006511:Hepatitis B Antigens / Q000032:analysis / Q000648:ultrastructure; D006514:Hepatitis B Surface Antigens / Q000032:analysis; D006515:Hepatitis B virus / Q000276:immunology; D006801:Humans; D007111:Immunity, Cellular; D007116:Immunization, Passive; D008113:Liver Neoplasms / Q000276:immunology; D014765:Viral Vaccines
D000914:Antibodies, Viral; D000939:Epitopes; D006511:Hepatitis B Antigens; D006514:Hepatitis B Surface Antigens; D014765:Viral Vaccines